Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$4.70 -0.03 (-0.63%)
As of 12:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LFMD vs. PNTG, AVAH, CSTL, AUNA, FLGT, SBC, TALK, DCGO, INNV, and CELC

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Auna (AUNA), Fulgent Genetics (FLGT), SBC Medical Group (SBC), Talkspace (TALK), DocGo (DCGO), InnovAge (INNV), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

LifeMD vs.

The Pennant Group (NASDAQ:PNTG) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.

The Pennant Group has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$652.30M1.18$13.38M$0.7032.03
LifeMD$193.06M1.03-$20.60M-$0.64-7.20

The Pennant Group currently has a consensus price target of $36.00, indicating a potential upside of 60.56%. LifeMD has a consensus price target of $11.14, indicating a potential upside of 141.87%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
LifeMD
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

In the previous week, The Pennant Group had 13 more articles in the media than LifeMD. MarketBeat recorded 15 mentions for The Pennant Group and 2 mentions for LifeMD. LifeMD's average media sentiment score of 0.38 beat The Pennant Group's score of 0.07 indicating that LifeMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
2 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeMD
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

The Pennant Group has a net margin of 3.24% compared to LifeMD's net margin of -12.06%. The Pennant Group's return on equity of 13.47% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group3.24% 13.47% 3.81%
LifeMD -12.06%N/A -36.34%

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 5.8% of The Pennant Group shares are held by insiders. Comparatively, 16.0% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

The Pennant Group has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500.

The Pennant Group received 4 more outperform votes than LifeMD when rated by MarketBeat users. However, 75.00% of users gave LifeMD an outperform vote while only 45.98% of users gave The Pennant Group an outperform vote.

CompanyUnderperformOutperform
The Pennant GroupOutperform Votes
40
45.98%
Underperform Votes
47
54.02%
LifeMDOutperform Votes
36
75.00%
Underperform Votes
12
25.00%

Summary

The Pennant Group beats LifeMD on 12 of the 18 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$201.14M$1.30B$5.81B$8.30B
Dividend YieldN/AN/A4.76%3.97%
P/E Ratio-7.2617.3324.7818.99
Price / Sales1.031.32372.02107.51
Price / CashN/A36.0138.0534.62
Price / Book30.718.537.204.20
Net Income-$20.60M-$52.07M$3.18B$246.82M
7 Day Performance-7.30%-6.79%-4.01%-4.63%
1 Month Performance-27.10%-12.73%-7.80%-7.79%
1 Year Performance-38.90%-8.37%11.13%2.41%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
2.0418 of 5 stars
$4.70
-0.6%
$11.14
+137.1%
-40.9%$203.57M$193.06M-7.34230
PNTG
The Pennant Group
3.7435 of 5 stars
$25.15
+0.4%
$36.00
+43.1%
+23.2%$863.90M$544.89M36.995,791Positive News
AVAH
Aveanna Healthcare
0.8956 of 5 stars
$4.14
-2.1%
$4.51
+9.0%
+68.6%$799.97M$1.90B-12.1833,500Gap Down
CSTL
Castle Biosciences
1.8691 of 5 stars
$25.36
-1.5%
$40.29
+58.9%
+6.7%$710.33M$219.79M126.81540Analyst Revision
Gap Down
AUNA
Auna
3.8729 of 5 stars
$8.06
-0.6%
$13.53
+67.8%
N/A$595.80M$1.04B0.0014,958Upcoming Earnings
Short Interest ↓
News Coverage
FLGT
Fulgent Genetics
3.7747 of 5 stars
$16.75
+1.8%
$22.00
+31.3%
-34.3%$512.33M$277.76M-3.031,184Short Interest ↑
SBC
SBC Medical Group
N/A$4.70
+3.1%
N/AN/A$484.19MN/A0.00N/ANews Coverage
TALK
Talkspace
4.4022 of 5 stars
$2.85
-5.3%
$4.38
+53.5%
-7.0%$481.42M$187.59M285.29500Insider Trade
Positive News
DCGO
DocGo
2.4958 of 5 stars
$4.44
-7.3%
$6.10
+37.4%
-27.6%$453.11M$694.97M15.864,164Analyst Revision
INNV
InnovAge
1.3028 of 5 stars
$3.32
flat
$5.00
+50.6%
-33.5%$449.00M$763.85M-17.472,350Short Interest ↑
Gap Up
CELC
Celcuity
2.339 of 5 stars
$11.18
-15.0%
$30.17
+169.8%
-48.9%$415.11MN/A-4.2840Positive News

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners